Literature DB >> 26595616

Essential medicines are still essential.

Andy L Gray1, Veronika J Wirtz2, Ellen F M 't Hoen3, Michael R Reich4, Hans V Hogerzeil5.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26595616     DOI： 10.1016/S0140-6736(15)00514-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Drug combination therapy increases successful drug repositioning.

Authors:  Wei Sun; Philip E Sanderson; Wei Zheng
Journal:  Drug Discov Today       Date:  2016-05-27       Impact factor: 7.851

Review 2.  Essential medicines for universal health coverage.

Authors:  Veronika J Wirtz; Hans V Hogerzeil; Andrew L Gray; Maryam Bigdeli; Cornelis P de Joncheere; Margaret A Ewen; Martha Gyansa-Lutterodt; Sun Jing; Vera L Luiza; Regina M Mbindyo; Helene Möller; Corrina Moucheraud; Bernard Pécoul; Lembit Rägo; Arash Rashidian; Dennis Ross-Degnan; Peter N Stephens; Yot Teerawattananon; Ellen F M 't Hoen; Anita K Wagner; Prashant Yadav; Michael R Reich
Journal:  Lancet       Date:  2016-11-08       Impact factor: 79.321

3.  Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level.

Authors:  B Todesco; G Ostuzzi; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2022-04-19       Impact factor: 7.818

4.  Estimated Financing Amount Needed for Essential Medicines in China, 2014.

Authors:  Wei Xu; Zheng-Yuan Xu; Gong-Jie Cai; Chiao-Yun Kuo; Jing Li; Yi-Syuan Huang
Journal:  Chin Med J (Engl)       Date:  2016-03-20       Impact factor: 2.628

5.  Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference.

Authors:  Sabine Vogler; Nina Zimmermann; Alessandra Ferrario; Veronika J Wirtz; Kees de Joncheere; Hanne Bak Pedersen; Guillaume Dedet; Valérie Paris; Aukje K Mantel-Teeuwisse; Zaheer-Ud-Din Babar
Journal:  J Pharm Policy Pract       Date:  2016-03-15

6.  WHO and national lists of essential medicines in Mexico, Central and South America, and the Caribbean: are they adequate to promote paediatric endocrinology and diabetes care?

Authors:  Amanda Rowlands; Alejandra Acosta-Gualandri; Jaime Guevara-Aguirre; Jean-Pierre Chanoine
Journal:  BMJ Glob Health       Date:  2016-10-27

7.  Multi-disciplinary patient-centered model for the expedited provision of costly therapies in community settings: the case of new medication for hepatitis C.

Authors:  Nitzan Avisar; Yael Heller; Clara Weil; Aviva Ben-Baruch; Shani Potesman-Yona; Ran Oren; Gabriel Chodick; Varda Shalev; Nachman Ash
Journal:  Isr J Health Policy Res       Date:  2017-09-28

8.  Should COVID-19 Vaccines Authorized for Emergency Use Be Considered "Essential" Medicines?

Authors:  Maxwell J Smith; Lisa Forman; Michael Parker; Katrina Perehudoff; Belinda Rawson; Sharifah Sekalala
Journal:  Health Hum Rights       Date:  2021-06

9.  Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint.

Authors:  Raffaella Ravinetto; Anja De Weggheleire; Thomas P C Dorlo; Sven Francque; An Sokkab; Corinne Pouget; Bruno Meessen; Patricia Tabernero; Paul N Newton; Lut Lynen
Journal:  Trop Med Int Health       Date:  2016-10-17       Impact factor: 2.622

10.  How the Uruguayan Judiciary Shapes Access to High-Priced Medicines: A Critique through the Right to Health Lens.

Authors:  Lucía Berro Pizzarossa; Katrina Perehudoff; José Castela Forte
Journal:  Health Hum Rights       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.